Synovus Financial Corp Tg Therapeutics, Inc. Transaction History
Synovus Financial Corp
- $8.01 Billion
- Q2 2025
A detailed history of Synovus Financial Corp transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Synovus Financial Corp holds 13,500 shares of TGTX stock, worth $459,270. This represents 0.01% of its overall portfolio holdings.
Number of Shares
13,500
Previous 18,000
25.0%
Holding current value
$459,270
Previous $709,000
31.59%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding TGTX
# of Institutions
406Shares Held
91.6MCall Options Held
2.28MPut Options Held
1.68M-
Vanguard Group Inc Valley Forge, PA15.8MShares$538 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$387 Million0.0% of portfolio
-
State Street Corp Boston, MA7.62MShares$259 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.49MShares$119 Million0.01% of portfolio
-
Clearbridge Investments, LLC New York, NY3.05MShares$104 Million0.09% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $4.94B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...